Loading...
Loading...
Loading...
Loading...
No reviews have been added for this product.
MBL Life Sciences
| Product Specifications | |
| Application | FC |
| Reactivity | Mouse |
| Conjugation | PE |
| Immunogen | SIY |
| Peptide Sequence | SIYRYYGL |
| Class | Class I |
| Sequence Location | - |
| MHC Allele | H-2Kb |
| Documents & Links for H-2Kb Negative Tetramer-SIYRYYGL-PE | |
| Datasheet | H-2Kb Negative Tetramer-SIYRYYGL-PE Datasheet |
| Documents & Links for H-2Kb Negative Tetramer-SIYRYYGL-PE | |
| Datasheet | H-2Kb Negative Tetramer-SIYRYYGL-PE Datasheet |
| Citations for H-2Kb Negative Tetramer-SIYRYYGL-PE – 5 Found |
| Wakita, Daiko; Chamoto, Kenji; Zhang, Yue; Narita, Yoshinori; Noguchi, Daisuke; Ohnishi, Hideaki; Iguchi, Takeshi; Sakai, Tomoaki; Ikeda, Hiroaki; Nishimura, Takashi. An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen. International Immunology. 2006;18(3):425-34. PubMed |
| Chamoto, Kenji; Wakita, Daiko; Narita, Yoshinori; Zhang, Yue; Noguchi, Daisuke; Ohnishi, Hideaki; Iguchi, Takeshi; Sakai, Tomoaki; Ikeda, Hiroaki; Nishimura, Takashi. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy. Cancer Research. 2006;66(3):1809-17. PubMed |
| Asano, Jumpei; Tada, Hiroyuki; Onai, Nobuyuki; Sato, Taku; Horie, Yasuo; Fujimoto, Yukari; Fukase, Koichi; Suzuki, Akira; Mak, Tak W; Ohteki, Toshiaki. Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo. Journal Of Immunology (Baltimore, Md. : 1950). 2010;184(2):736-45. PubMed |
| Du, Xuexiang; Tang, Fei; Liu, Mingyue; Su, Juanjuan; Zhang, Yan; Wu, Wei; Devenport, Martin; Lazarski, Christopher A; Zhang, Peng; Wang, Xu; Ye, Peiying; Wang, Changyu; Hwang, Eugene; Zhu, Tinghui; Xu, Ting; Zheng, Pan; Liu, Yang. A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy. Cell Research. 2018;28(4):416-432. PubMed |
| Sivick, Kelsey E; Desbien, Anthony L; Glickman, Laura Hix; Reiner, Gabrielle L; Corrales, Leticia; Surh, Natalie H; Hudson, Thomas E; Vu, Uyen T; Francica, Brian J; Banda, Tamara; Katibah, George E; Kanne, David B; Leong, Justin J; Metchette, Ken; Bruml, Jacob R; Ndubaku, Chudi O; McKenna, Jeffrey M; Feng, Yan; Zheng, Lianxing; Bender, Steven L; Cho, Charles Y; Leong, Meredith L; van Elsas, Andrea; Dubensky, Thomas W Jr; McWhirter, Sarah M. Magnitude of Therapeutic STING Activation Determines CD8(+) T Cell-Mediated Anti-tumor Immunity. Cell Reports. 2018;25(11):3074-3085.e5. PubMed |
MBL Life Sciences
| Product Specifications | |
| Application | FC |
| Reactivity | Mouse |
| Conjugation | PE |
| Immunogen | SIY |
| Peptide Sequence | SIYRYYGL |
| Class | Class I |
| Sequence Location | - |
| MHC Allele | H-2Kb |
| Documents & Links for H-2Kb Negative Tetramer-SIYRYYGL-PE | |
| Datasheet | H-2Kb Negative Tetramer-SIYRYYGL-PE Datasheet |
| Documents & Links for H-2Kb Negative Tetramer-SIYRYYGL-PE | |
| Datasheet | H-2Kb Negative Tetramer-SIYRYYGL-PE Datasheet |
| Citations for H-2Kb Negative Tetramer-SIYRYYGL-PE – 5 Found |
| Wakita, Daiko; Chamoto, Kenji; Zhang, Yue; Narita, Yoshinori; Noguchi, Daisuke; Ohnishi, Hideaki; Iguchi, Takeshi; Sakai, Tomoaki; Ikeda, Hiroaki; Nishimura, Takashi. An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen. International Immunology. 2006;18(3):425-34. PubMed |
| Chamoto, Kenji; Wakita, Daiko; Narita, Yoshinori; Zhang, Yue; Noguchi, Daisuke; Ohnishi, Hideaki; Iguchi, Takeshi; Sakai, Tomoaki; Ikeda, Hiroaki; Nishimura, Takashi. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy. Cancer Research. 2006;66(3):1809-17. PubMed |
| Asano, Jumpei; Tada, Hiroyuki; Onai, Nobuyuki; Sato, Taku; Horie, Yasuo; Fujimoto, Yukari; Fukase, Koichi; Suzuki, Akira; Mak, Tak W; Ohteki, Toshiaki. Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo. Journal Of Immunology (Baltimore, Md. : 1950). 2010;184(2):736-45. PubMed |
| Du, Xuexiang; Tang, Fei; Liu, Mingyue; Su, Juanjuan; Zhang, Yan; Wu, Wei; Devenport, Martin; Lazarski, Christopher A; Zhang, Peng; Wang, Xu; Ye, Peiying; Wang, Changyu; Hwang, Eugene; Zhu, Tinghui; Xu, Ting; Zheng, Pan; Liu, Yang. A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy. Cell Research. 2018;28(4):416-432. PubMed |
| Sivick, Kelsey E; Desbien, Anthony L; Glickman, Laura Hix; Reiner, Gabrielle L; Corrales, Leticia; Surh, Natalie H; Hudson, Thomas E; Vu, Uyen T; Francica, Brian J; Banda, Tamara; Katibah, George E; Kanne, David B; Leong, Justin J; Metchette, Ken; Bruml, Jacob R; Ndubaku, Chudi O; McKenna, Jeffrey M; Feng, Yan; Zheng, Lianxing; Bender, Steven L; Cho, Charles Y; Leong, Meredith L; van Elsas, Andrea; Dubensky, Thomas W Jr; McWhirter, Sarah M. Magnitude of Therapeutic STING Activation Determines CD8(+) T Cell-Mediated Anti-tumor Immunity. Cell Reports. 2018;25(11):3074-3085.e5. PubMed |
